Related Experiment Video
Updated: May 8, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism
James M Murphy1, Peter E Czabotar, Joanne M Hildebrand
1The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, VIC 3050, Australia.
Abstract:
Mixed lineage kinase domain-like (MLKL) is a component of the "necrosome," the multiprotein complex that triggers tumor necrosis factor (TNF)-induced cell death by necroptosis. To define the specific role and molecular mechanism of MLKL action, we generated MLKL-deficient mice and solved the crystal structure of MLKL. Although MLKL-deficient mice were viable and displayed no hematopoietic anomalies or other obvious pathology, cells derived from these animals were resistant to TNF-induced necroptosis unless MLKL expression was restored. Structurally, MLKL comprises a four-helical bundle tethered to the pseudokinase domain, which contains an unusual pseudoactive site. Although the pseudokinase domain binds ATP, it is catalytically inactive and its essential nonenzymatic role in necroptotic signaling is induced by receptor-interacting serine-threonine kinase 3 (RIPK3)-mediated phosphorylation. Structure-guided mutation of the MLKL pseudoactive site resulted in constitutive, RIPK3-independent necroptosis, demonstrating that modification of MLKL is essential for propagation of the necroptosis pathway downstream of RIPK3.
Insights
Mixed lineage kinase domain-like (MLKL) is crucial for tumor necrosis factor-induced necroptosis. MLKL-deficient cells resist this cell death pathway, highlighting MLKL
Area of Science:
- Cellular Biology
- Molecular Biology
- Immunology
Background:
- Mixed lineage kinase domain-like (MLKL) is a key component of the necrosome complex.
- The necrosome complex mediates tumor necrosis factor (TNF)-induced necroptosis, a form of programmed cell death.
Purpose of the Study:
- To elucidate the specific role and molecular mechanism of MLKL in necroptosis.
- To generate MLKL-deficient mice for functional studies and determine the MLKL structure.
Main Methods:
- Generation and analysis of MLKL-deficient mice.
- X-ray crystallography to solve the MLKL protein structure.
- Site-directed mutagenesis to probe MLKL pseudoactive site function.
Main Results:
- MLKL-deficient cells are resistant to TNF-induced necroptosis, confirming MLKL's essential role.
- The crystal structure revealed MLKL's pseudokinase domain binds ATP but is catalytically inactive.
- RIPK3-mediated phosphorylation induces MLKL's nonenzymatic function in necroptosis.
- Mutations in the MLKL pseudoactive site lead to RIPK3-independent necroptosis.
Conclusions:
- MLKL is indispensable for TNF-induced necroptosis signaling.
- The pseudokinase domain's activity is regulated by RIPK3 phosphorylation, not intrinsic catalysis.
- MLKL modification is critical for propagating the necroptosis pathway downstream of RIPK3.
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
MAPK Signaling Cascades
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
